Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment

Background/Aim: KRAS mutations are reported in 20-25% of non-small cell lung cancer (NSCLC) and their prognostic role is unclear. We studied KRAS and EGFR genotyping in Greek NSCLC patients. Patients and Methods: KRAS and EGFR genotypes were centrally evaluated in 421 NSCLC patients (diagnosed Septe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Genomics Proteomics
Autores principales: LINARDOU, HELENA, KOTOULA, VASSILIKI, KOUVATSEAS, GEORGE, MOUNTZIOS, GIANNIS, KARAVASILIS, VASILIOS, SAMANTAS, EPAMINONDAS, KALOGERA-FOUNTZILA, ANNA, TELEVANTOU, DESPINA, PAPADOPOULOU, KYRIAKI, MAVROPOULOU, XANTHIPI, DASKALAKI, EMILY, ZARAMBOUKAS, THOMAS, EFSTRATIOU, IOANNIS, LAMPAKI, SOFIA, RALLIS, GRIGORIOS, RES, ELENI, SYRIGOS, Ν. KONSTANTINOS, KOSMIDIS, Α. PARIS, PECTASIDES, DIMITRIOS, FOUNTZILAS, GEORGE
Formato: Artigo
Lenguaje:Inglês
Publicado: International Institute of Anticancer Research 2019
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6885370/
https://ncbi.nlm.nih.gov/pubmed/31659106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/cgp.20155
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares